Status:

TERMINATED

Effectiveness of Corticosteroid vs. Ketorolac Shoulder Injections: A Prospective Double-Blinded Randomized Trial

Lead Sponsor:

Michael Khazzam

Conditions:

Full Thickness Rotator Cuff Tear

Rotator Cuff Tendinitis

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

The purpose of this study is to compare the functional outcomes of patients with shoulder pathology treated with either ketorolac or corticosteroid injections, in a randomized double-blinded study. In...

Detailed Description

The proposed study is a three arm, double-blinded, prospective randomized controlled clinical trial with follow-up immediately after the injection and at day 2, and weeks 1, 2, 4, 6, and 12. In this s...

Eligibility Criteria

Inclusion

  • Rotator Cuff Tendinitis
  • Atraumatic Rotator Cuff Tear
  • Rotator Cuff Tear Arthropathy
  • Subjects who speak English

Exclusion

  • Age: \< 18 years old
  • Prior Shoulder Surgery
  • Fracture
  • Acute Traumatic Rotator Cuff Tear
  • Infection
  • Uncontrolled Diabetes Mellitus (HbA1c \>8)
  • Recent Prior Shoulder Injection in either the Subacromial space
  • Workers Compensation
  • History of Gastric Ulcers
  • Tumor Involving the Shoulder Region
  • Prior history of gastrointestinal bleeding, allergic reactions, impaired renal function, seizures or cardiac arrhythmias
  • Subject unable to provide informed consent
  • Subjects who don't speak English
  • Patients who are pregnant or lactating at time of screening or are of child bearing age
  • Patients currently receiving an aspirin, NSAID regimen or any other anti-inflammatory agents that could affect inflammation response.
  • Patients with any bleeding disorders.
  • Patients with severe renal failure.
  • Patients likely to have severe problems maintaining follow-up, including patients diagnosed with severe psychiatric conditions, patients who live too far outside the hospital's catchment area, patients who are incarcerated and patients who have unstable housing situations.
  • Patients who are allergic to aspirin, ketorolac tromethamine and other NSAIDs

Key Trial Info

Start Date :

May 1 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 14 2017

Estimated Enrollment :

82 Patients enrolled

Trial Details

Trial ID

NCT04115644

Start Date

May 1 2017

End Date

September 14 2017

Last Update

December 14 2023

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

John Hopkins Shoulder & Sports Medicine

Baltimore, Maryland, United States, 21205

2

University of Texas Southwestern Medical Center

Dallas, Texas, United States, 75390

Effectiveness of Corticosteroid vs. Ketorolac Shoulder Injections: A Prospective Double-Blinded Randomized Trial | DecenTrialz